Drug Database
ON

ondansetron (ondansetron, ODT / Zofran ODT)

✓ Approved

GSK · HTR3A · 小分子

什么是 ondansetron?

ondansetron 是一种小分子,由GSK研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名ondansetron, ODT, Zofran ODT
公司GSK
药物类别小分子
分子靶点HTR3A
给药途径Oral (PO)
状态Approved

作用机制

分子靶点

ondansetron 作用于 1 个分子靶点:

HTR3A5-hydroxytryptamine receptor 3A (5-HT3R, 5-HT-3)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

相关研究文献

PubMedInternational journal of molecular sciences2026-10-27

Modulation of the Liver-Brain Axis by Ondansetron in Thio-Acetamide-Induced Acute Hepatic Encephalopathy.

Sari Fatih Mehmet FM, Bilgin Yasin Y, Cicek Betul B, Kurt Engin E et al.

Hepatic encephalopathy (HE) is a severe neurological complication of liver failure characterized by hyperammonemia, oxidative stress, neuroinflammation, and progressive neuronal dysfunction. Ondansetron (OND), a selective 5-hydroxytryptamine-3 (5-HT3) receptor antagonist, has reported anti-inflammatory and neuroactive properties, but its effects in HE remain poorly defined. This study evaluated OND in a thioacetamide (TAA)-induced acute HE model in female Sprague-Dawley rats. Animals were assigned to Control, TAA, OND, TAA+OND (0.5 mg/kg), and TAA+OND (1 mg/kg) groups. Serum and cerebral glutamine, oxidative and antioxidant parameters, histopathological alterations, and TLR2, NF-κB, IL-1β, GFAP, NLRP3, and caspase-1 immunoreactivity were assessed in liver and brain tissues. TAA increased glutamine accumulation, produced tissue injury, altered redox parameters, and increased several inflammation-related markers. OND significantly reduced cerebral glutamine and attenuated selected biochemical, histopathological, and immunohistochemical alterations, with generally more pronounced effects at 0.5 mg/kg. These findings indicate that OND administration is associated with partial modulation of metabolic, oxidative, inflammatory, and structural alterations in TAA-treated rats, warranting further receptor-specific and functional studies to clarify its mechanisms and therapeutic relevance.

PMID 42942034
阅读全文 →
PubMedNanomaterials (Basel, Switzerland)2026-10-26

Understanding Organic Adlayer Formation on CoOx-Terminated PtCoO2.

Hazeldine Kerry K, Soulié Jean-Philippe JP, Vehkamäki Marko M, Ritala Mikko M et al.

PtCoO2 is an attractive candidate for next-generation interconnects due to its exceptionally low in-plane resistivity, but its susceptibility to degradation under reducing conditions necessitates effective surface passivation strategies. In this work, the deposition of organic adlayers on PtCoO2 was systematically investigated using octadecylphosphonic acid (ODPA), octylphosphonic acid (OPA), 1-octadecanethiol (ODT), and trifluoroacetic acid (TFA). The influence of immersion time (0.5-48 h) and surface pre-treatment (untreated, ethanol-cleaned, and UV-ozone-treated surfaces) was evaluated using water contact angle (WCA), X-ray photoelectron spectroscopy (XPS), and atomic force microscopy (AFM). Low-energy ion scattering (LEIS) confirmed a CoOx-rich surface termination, which strongly influenced adsorption behaviour. Among the molecules studied, phosphonic acids exhibited the strongest interaction with the surface, with ODPA producing the highest WCAs (97-99°) and clear evidence of phosphonate bonding. Comparison with OPA revealed the importance of alkyl chain length in promoting hydrophobicity and molecular organisation, yielding values of 77-88°. In contrast, ODT exhibited heterogeneous adsorption, sulphur oxidation, and aggregate formation, while TFA showed limited surface retention. Overall, ODPA was identified as the most effective adsorbate, establishing phosphonic acid-based self-assembled monolayers as promising candidates for the passivation of PtCoO2 and related conductive oxide materials.

PMID 42931280
阅读全文 →
PubMedLangmuir : the ACS journal of surfaces and colloids2026-10-23

Correlating Force-Conductance-Structure in Au-1,8-Octanedithiol-Au Molecular Electronics.

Wang Huachuan H, Ma Xiangyu X, Li Qinrao Q, Rao Qi Q et al.

Because atomic-scale junction configurations cannot be directly resolved during break-junction measurements, simulations are needed to connect experimental force and conductance signatures with plausible interfacial structures. Here, we use configurational-bias Monte Carlo, driven molecular dynamics, and DFT+NEGF transport calculations to interpret the electromechanical response of Au-1,8-octanedithiol (ODT)-Au junctions measured by conductive atomic force microscopy break-junction experiments. Under cyclic stretching and compression with a modulation amplitude of 1.2 Å, reproducible force and conductance responses are observed. The simulations generate metastable configurations containing one, two, and three bridging ODT molecules and reproduce characteristic force ranges and conductance levels consistent with experiment. Structural analysis reveals configuration-dependent load distribution, junction deformation, molecular reorientation, and local Au-S coordination. The DFT+NEGF results further show that conductance modulation is governed mainly by changes in the Au-S contacts rather than deformation of the alkane backbone. These findings provide an atomistic interpretation of the measured electromechanical responses and clarify how junction configuration and contact rearrangement influence transport in Au-ODT-Au molecular junctions.

PMID 42918148
阅读全文 →
PubMedAmerican journal of therapeutics2026-10-23

Does Repeated-Dose Ondansetron Provide Additional Benefit in Children with Acute Gastroenteritis? A Systematic Review and Meta-Analysis.

Fonseca Caio Henrique Prado CHP, Sobral Milene Vitória Sampaio MVS, Cordeiro E Silva José Henrique JH

PMID 42912510
阅读全文 →
PubMedPharmaceutical science advances2026-10-20

Corrigendum to "D-pinitol modulates the anti-emetic effects of aprepitant, domperidone, and ondansetron in chicks" [Pharmaceut. Sci. Adv. 3, (2025), 100073].

Rahman Elit E, Rahman Anisur A, Sheikh Salehin S, Polash Jannatul Islam JI et al.

[This corrects the article DOI: 10.1016/j.pscia.2025.100073.].

PMID 42898476
阅读全文 →
PubMedInnovations in clinical neuroscience2026-10-20

Concurrent Management of Adolescent Cannabinoid Hyperemesis Syndrome and Delirium With Haloperidol.

Hsu Jeremiah J, Kotdawala Mahaksh M, Priolo Thomas T

Cannabinoid hyperemesis syndrome (CHS) manifests in adults as severe nausea accompanied by episodic vomiting and intense abdominal pain, typically associated with prolonged, high-dose cannabis use. The clinical course of CHS is divided into 3 distinct phases: prodromal, hyperemetic, and recovery. Traditional antiemetic and antinausea medications, such as ondansetron and metoclopramide, are often used in the acute clinical setting to address these isolated symptoms. Discussions and occasional use of haloperidol have demonstrated a level of symptom relief in patients with CHS. In several instances, patients report complete resolution of symptoms previously refractory to, or only partially relieved by, traditional antiemetics and antinausea medications. This case report explores the hospital course of a 15-year-old female adolescent who presented to the emergency department with a recurrent episode of CHS. The patient reported symptoms of nausea, intense abdominal pain, compulsive bathing behavior, physical agitation, and delirium. In the setting of CHS symptoms refractory to traditional antiemetics and concurrent behavioral disturbances, the patient was started on a standing low dose of haloperidol. Within 6 days of starting haloperidol treatment, the patient reported complete resolution of her presenting symptoms and was subsequently discharged from the hospital. We conclude that patients presenting with CHS and concurrent delirium, as is often the clinical presentation, would further benefit from the off-label use of haloperidol. Although minimal literature exists on the management of CHS, there is almost no evidence examining CHS comorbid with delirium and/or agitation. This report seeks to demonstrate the underlying causality and explore the scientific mechanisms to show the clear benefits of haloperidol as an antiemetic and antinausea medication, in addition to any sequelae of delirium, and highlighting the need for a revision of pre-existing CHS treatment protocols, specifically in the emergency department setting.

PMID 42899270
阅读全文 →

注册免费账户还可查看另外 6612 篇文献

免费注册查看全部文献 →

了解更多ondansetron